Clinical Trial Update: Pragmatic Geriatric Assessment Before CAR-T or Bispecific Antibody Therapy to Predict Side Effects and Outcomes in Older Patients (GA-ACT Trial)

View source ↗

Summary

A recruiting clinical study evaluating whether a pragmatic geriatric assessment before CAR-T cell therapy or bispecific antibody treatment can predict side effe…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diffuse Large B-cell Lymphoma
• Multiple Myeloma

Drugs mentioned

• Bispecific antibody therapy (bispecific antibody)
• CAR-T cell therapy

Snippet

Sponsor: University of Zurich | Conditions: Multiple Myeloma (MM), Lymphoma, Large B-Cell, Diffuse (DLBCL), Lymphoma, CART Therapy | Status: RECRUITING